Skip to content
healthcare.dev

LOQTORZI

NDC 70114-340, toripalimab-tpzi, injection, from Coherus Oncology, Inc..

Product NDC
70114-340
Status
Listed
Labeler
Coherus Oncology, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761240
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70114-340 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TORIPALIMAB240 mg/6mL

Pharmacologic classes

Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
70114-340-01701140340011 VIAL, GLASS in 1 CARTON (70114-340-01) / 6 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/82e7921a-1e84-4988-9799-0ad7d19b2a75
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70114-340

Use it

Look up 70114-340 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70114-340 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70114-340. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.